Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[@vjoncology](/creator/youtube/vjoncology)
"NIFTY: liposomal irinotecan in combination with 5FU and leucovorin in patients with mBTC"  
[YouTube Link](https://youtube.com/watch?v=0YuQ6PNvl_g) [@vjoncology](/creator/youtube/vjoncology) 2021-07-08T15:02Z 15.6K followers, XXX engagements


"Melanoma at ESMO 2025: SWOG S1801 NADINA and more"  
[YouTube Link](https://youtube.com/watch?v=76Gn2EgcAUE) [@vjoncology](/creator/youtube/vjoncology) 2025-10-19T09:32Z 15.6K followers, XX engagements


"Highlights from ESMO 2025"  
[YouTube Link](https://youtube.com/watch?v=W4ZKV5TLcPk) [@VJOncology](/creator/youtube/VJOncology) 2025-10-24T16:18Z 15.6K followers, XX engagements


"OBP101JP: final results of oncolytic virotherapy + suratadenoturev + RT for esophageal cancer"  
[YouTube Link](https://youtube.com/watch?v=cj1qZ5IPko0) [@vjoncology](/creator/youtube/vjoncology) 2025-10-20T15:23Z 15.6K followers, XXX engagements


"EMBARK: final OS results of enzalutamide in hrBCR prostate cancer"  
[YouTube Link](https://youtube.com/watch?v=rVgkdIr5FBw) [@vjoncology](/creator/youtube/vjoncology) 2025-10-20T11:49Z 15.6K followers, XX engagements


"OptiTROP-Lung04: sacituzumab tirumotecan in EGFR-mutated NSCLC"  
[YouTube Link](https://youtube.com/watch?v=3D8hQZNDe-Y) [@vjoncology](/creator/youtube/vjoncology) 2025-10-23T16:15Z 15.6K followers, XX engagements


"5-year follow-up of CheckMate 648: NIVO plus chemo or IPI vs chemo as 1L treatment for advanced ESCC"  
[YouTube Link](https://youtube.com/watch?v=4av3F4uNYPg) [@vjoncology](/creator/youtube/vjoncology) 2025-10-20T13:36Z 15.6K followers, XX engagements


"FORAGER-1: dose optimization of LY3866288 in FGFR3-altered tumors"  
[YouTube Link](https://youtube.com/watch?v=8KRENmnchO8) [@vjoncology](/creator/youtube/vjoncology) 2025-10-22T09:59Z 15.6K followers, XX engagements


"NIAGARA: HRQoL outcomes of perioperative durvalumab in MIBC"  
[YouTube Link](https://youtube.com/watch?v=9nD9kGK2Pgk) [@vjoncology](/creator/youtube/vjoncology) 2025-10-22T10:50Z 15.6K followers, XX engagements


"The potential of spatial biology & clonal evolution mapping to transform precision cancer treatment"  
[YouTube Link](https://youtube.com/watch?v=EIQxxTHivnQ) [@VJOncology](/creator/youtube/VJOncology) 2025-10-20T17:52Z 15.6K followers, XX engagements


"Capturing clonal evolution of ccRCC through histology"  
[YouTube Link](https://youtube.com/watch?v=HweaK5uF1wQ) [@vjoncology](/creator/youtube/vjoncology) 2025-10-20T17:43Z 15.6K followers, XX engagements


"Practice-changing CRC cancer trials at ASCO 2025: ATOMIC & CheckMate 8HW"  
[YouTube Link](https://youtube.com/watch?v=JBE8kfGzQj4) [@VJOncology](/creator/youtube/VJOncology) 2025-06-05T10:46Z 15.6K followers, XXX engagements


"Three vs six cycles of platinum-based chemotherapy for aUC in the DISCUS trial"  
[YouTube Link](https://youtube.com/watch?v=JML3v6NawRM) [@vjoncology](/creator/youtube/vjoncology) 2025-10-23T16:18Z 15.6K followers, XX engagements


"ENZARAD: enzalutamide with ADT and radiation in high-risk prostate cancer"  
[YouTube Link](https://youtube.com/watch?v=L6sB-uV1wbM) [@vjoncology](/creator/youtube/vjoncology) 2025-10-23T11:28Z 15.6K followers, XX engagements


"Neoadjuvant nivolumab with or without visugromab in cisplatin-ineligible MIBC"  
[YouTube Link](https://youtube.com/watch?v=LIUEYok9c_g) [@vjoncology](/creator/youtube/vjoncology) 2025-10-23T16:36Z 15.6K followers, XX engagements


"IMvigor011: ctDNA-guided adjuvant atezolizumab in MIBC"  
[YouTube Link](https://youtube.com/watch?v=Mu4eFZAPxkw) [@vjoncology](/creator/youtube/vjoncology) 2025-10-22T12:58Z 15.6K followers, XX engagements


"Management of interstitial lung disease in the DESTINY-Breast05 trial"  
[YouTube Link](https://youtube.com/watch?v=P2iPlS1lFFw) [@vjoncology](/creator/youtube/vjoncology) 2025-10-22T12:55Z 15.6K followers, XX engagements


"CARES-009: perioperative camrelizumab and rivoceranib in resectable HCC"  
[YouTube Link](https://youtube.com/watch?v=Q1xNps3ZxyQ) [@vjoncology](/creator/youtube/vjoncology) 2025-10-23T11:56Z 15.6K followers, XX engagements


"DESTINY-Breast05: T-DXd vs T-DM1 in high-risk HER2+ early breast cancer"  
[YouTube Link](https://youtube.com/watch?v=R3C9KfnZ1EE) [@vjoncology](/creator/youtube/vjoncology) 2025-10-22T12:53Z 15.6K followers, XX engagements


"CheckMate 8HW: nivolumab & ipilimumab in MSI-H/dMMR metastatic CRC"  
[YouTube Link](https://youtube.com/watch?v=UzupwedDjuI) [@vjoncology](/creator/youtube/vjoncology) 2025-10-22T14:36Z 15.6K followers, XX engagements


"BURAN: buparlisib and paclitaxel in pre-treated HNSCC"  
[YouTube Link](https://youtube.com/watch?v=XEoMSmRWaaw) [@vjoncology](/creator/youtube/vjoncology) 2025-10-23T16:56Z 15.6K followers, XX engagements


"DISCUS: comparing X vs X chemotherapy cycles before avelumab in aUC"  
[YouTube Link](https://youtube.com/watch?v=_z8Y2ysRCwQ) [@vjoncology](/creator/youtube/vjoncology) 2025-10-22T10:09Z 15.6K followers, XX engagements


"First line IO102-IO103 vaccine plus pembrolizumab in advanced melanoma"  
[YouTube Link](https://youtube.com/watch?v=aX6bpZDesCQ) [@vjoncology](/creator/youtube/vjoncology) 2025-10-23T11:26Z 15.6K followers, XX engagements


"SWOG S1801: 3-year outcomes of neoadjuvant-adjuvant pembrolizumab"  
[YouTube Link](https://youtube.com/watch?v=exJeDv0uzTk) [@vjoncology](/creator/youtube/vjoncology) 2025-10-20T14:07Z 15.6K followers, XX engagements


"PATHFINDER II: assessing the efficacy and safety of a MCAD test"  
[YouTube Link](https://youtube.com/watch?v=jqwOhq7fRDA) [@vjoncology](/creator/youtube/vjoncology) 2025-10-23T16:13Z 15.6K followers, XX engagements


"Phase I trial of ASP3082 in KRAS G12D-positive solid tumors"  
[YouTube Link](https://youtube.com/watch?v=kraCMBrFvSQ) [@vjoncology](/creator/youtube/vjoncology) 2024-11-04T17:10Z 15.6K followers, XXX engagements


"RC48-C016: disitamab vedotin & toripalimab vs chemotherapy in HER2+ la/mUC"  
[YouTube Link](https://youtube.com/watch?v=rucT4oIVunU) [@vjoncology](/creator/youtube/vjoncology) 2025-10-22T10:48Z 15.6K followers, XX engagements


"IMbrave152/SKYSCRAPER-14: tiragolumab atezolizumab & bevacizumab in HCC"  
[YouTube Link](https://youtube.com/watch?v=s59zrSVcaD4) [@vjoncology](/creator/youtube/vjoncology) 2025-10-23T11:55Z 15.6K followers, XX engagements


"OPTIC RCC: efficacy of cabozantinib and nivolumab in cluster 1/2 metastatic ccRCC"  
[YouTube Link](https://youtube.com/watch?v=sbkc7DrEPEQ) [@vjoncology](/creator/youtube/vjoncology) 2025-10-20T17:28Z 15.6K followers, XX engagements


"ASCO 2025 highlights in breast cancer: ASCENT-04 SERENA-6 and more"  
[YouTube Link](https://youtube.com/watch?v=wDk_Bmjg0fo) [@vjoncology](/creator/youtube/vjoncology) 2025-07-28T11:28Z 15.6K followers, XXX engagements


"COSMIC-313: transcriptomic predictors of metastatic sites in RCC"  
[YouTube Link](https://youtube.com/watch?v=waG80H8q1ZE) [@vjoncology](/creator/youtube/vjoncology) 2025-10-23T16:36Z 15.6K followers, XX engagements


"Comparing atezolizumab & bevacizumab with STRIDE in advanced HCC"  
[YouTube Link](https://youtube.com/watch?v=yN20SWs1R-U) [@vjoncology](/creator/youtube/vjoncology) 2025-08-21T15:23Z 15.6K followers, XXX engagements


"Gut and oral microbiomes linked to chemotherapy outcomes in GI cancer"  
[YouTube Link](https://youtube.com/watch?v=yhj-Vg7S9PI) [@vjoncology](/creator/youtube/vjoncology) 2025-10-23T16:58Z 15.6K followers, XX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@vjoncology "NIFTY: liposomal irinotecan in combination with 5FU and leucovorin in patients with mBTC"
YouTube Link @vjoncology 2021-07-08T15:02Z 15.6K followers, XXX engagements

"Melanoma at ESMO 2025: SWOG S1801 NADINA and more"
YouTube Link @vjoncology 2025-10-19T09:32Z 15.6K followers, XX engagements

"Highlights from ESMO 2025"
YouTube Link @VJOncology 2025-10-24T16:18Z 15.6K followers, XX engagements

"OBP101JP: final results of oncolytic virotherapy + suratadenoturev + RT for esophageal cancer"
YouTube Link @vjoncology 2025-10-20T15:23Z 15.6K followers, XXX engagements

"EMBARK: final OS results of enzalutamide in hrBCR prostate cancer"
YouTube Link @vjoncology 2025-10-20T11:49Z 15.6K followers, XX engagements

"OptiTROP-Lung04: sacituzumab tirumotecan in EGFR-mutated NSCLC"
YouTube Link @vjoncology 2025-10-23T16:15Z 15.6K followers, XX engagements

"5-year follow-up of CheckMate 648: NIVO plus chemo or IPI vs chemo as 1L treatment for advanced ESCC"
YouTube Link @vjoncology 2025-10-20T13:36Z 15.6K followers, XX engagements

"FORAGER-1: dose optimization of LY3866288 in FGFR3-altered tumors"
YouTube Link @vjoncology 2025-10-22T09:59Z 15.6K followers, XX engagements

"NIAGARA: HRQoL outcomes of perioperative durvalumab in MIBC"
YouTube Link @vjoncology 2025-10-22T10:50Z 15.6K followers, XX engagements

"The potential of spatial biology & clonal evolution mapping to transform precision cancer treatment"
YouTube Link @VJOncology 2025-10-20T17:52Z 15.6K followers, XX engagements

"Capturing clonal evolution of ccRCC through histology"
YouTube Link @vjoncology 2025-10-20T17:43Z 15.6K followers, XX engagements

"Practice-changing CRC cancer trials at ASCO 2025: ATOMIC & CheckMate 8HW"
YouTube Link @VJOncology 2025-06-05T10:46Z 15.6K followers, XXX engagements

"Three vs six cycles of platinum-based chemotherapy for aUC in the DISCUS trial"
YouTube Link @vjoncology 2025-10-23T16:18Z 15.6K followers, XX engagements

"ENZARAD: enzalutamide with ADT and radiation in high-risk prostate cancer"
YouTube Link @vjoncology 2025-10-23T11:28Z 15.6K followers, XX engagements

"Neoadjuvant nivolumab with or without visugromab in cisplatin-ineligible MIBC"
YouTube Link @vjoncology 2025-10-23T16:36Z 15.6K followers, XX engagements

"IMvigor011: ctDNA-guided adjuvant atezolizumab in MIBC"
YouTube Link @vjoncology 2025-10-22T12:58Z 15.6K followers, XX engagements

"Management of interstitial lung disease in the DESTINY-Breast05 trial"
YouTube Link @vjoncology 2025-10-22T12:55Z 15.6K followers, XX engagements

"CARES-009: perioperative camrelizumab and rivoceranib in resectable HCC"
YouTube Link @vjoncology 2025-10-23T11:56Z 15.6K followers, XX engagements

"DESTINY-Breast05: T-DXd vs T-DM1 in high-risk HER2+ early breast cancer"
YouTube Link @vjoncology 2025-10-22T12:53Z 15.6K followers, XX engagements

"CheckMate 8HW: nivolumab & ipilimumab in MSI-H/dMMR metastatic CRC"
YouTube Link @vjoncology 2025-10-22T14:36Z 15.6K followers, XX engagements

"BURAN: buparlisib and paclitaxel in pre-treated HNSCC"
YouTube Link @vjoncology 2025-10-23T16:56Z 15.6K followers, XX engagements

"DISCUS: comparing X vs X chemotherapy cycles before avelumab in aUC"
YouTube Link @vjoncology 2025-10-22T10:09Z 15.6K followers, XX engagements

"First line IO102-IO103 vaccine plus pembrolizumab in advanced melanoma"
YouTube Link @vjoncology 2025-10-23T11:26Z 15.6K followers, XX engagements

"SWOG S1801: 3-year outcomes of neoadjuvant-adjuvant pembrolizumab"
YouTube Link @vjoncology 2025-10-20T14:07Z 15.6K followers, XX engagements

"PATHFINDER II: assessing the efficacy and safety of a MCAD test"
YouTube Link @vjoncology 2025-10-23T16:13Z 15.6K followers, XX engagements

"Phase I trial of ASP3082 in KRAS G12D-positive solid tumors"
YouTube Link @vjoncology 2024-11-04T17:10Z 15.6K followers, XXX engagements

"RC48-C016: disitamab vedotin & toripalimab vs chemotherapy in HER2+ la/mUC"
YouTube Link @vjoncology 2025-10-22T10:48Z 15.6K followers, XX engagements

"IMbrave152/SKYSCRAPER-14: tiragolumab atezolizumab & bevacizumab in HCC"
YouTube Link @vjoncology 2025-10-23T11:55Z 15.6K followers, XX engagements

"OPTIC RCC: efficacy of cabozantinib and nivolumab in cluster 1/2 metastatic ccRCC"
YouTube Link @vjoncology 2025-10-20T17:28Z 15.6K followers, XX engagements

"ASCO 2025 highlights in breast cancer: ASCENT-04 SERENA-6 and more"
YouTube Link @vjoncology 2025-07-28T11:28Z 15.6K followers, XXX engagements

"COSMIC-313: transcriptomic predictors of metastatic sites in RCC"
YouTube Link @vjoncology 2025-10-23T16:36Z 15.6K followers, XX engagements

"Comparing atezolizumab & bevacizumab with STRIDE in advanced HCC"
YouTube Link @vjoncology 2025-08-21T15:23Z 15.6K followers, XXX engagements

"Gut and oral microbiomes linked to chemotherapy outcomes in GI cancer"
YouTube Link @vjoncology 2025-10-23T16:58Z 15.6K followers, XX engagements

creator/youtube::UCn3u5oMgE00_qIex2IzGjYg/posts
/creator/youtube::UCn3u5oMgE00_qIex2IzGjYg/posts